<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="16247">Phospholipid</z:chebi> methylase and <z:chebi fb="0" ids="23447">cyclic nucleotide</z:chebi> phosphodiesterase activities were studied in human B lymphoïd hemopathies (51 patients: <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo>, B <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, hairy cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>) and compared with activities in lymphoblastïd and Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines and with <z:mpath ids='MPATH_458'>normal</z:mpath> B lymphocytes: methylase activity proved to be lower in ALL and high grade <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and inversely related to the percent of cells in S phase state; the A/G ratio of phosphodiesterases was low in ALL and CLL and high in hairy cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> and it was related to the percent of cells in S phase state </plain></SENT>
</text></document>